Companies
TriLink BioTechnologies
Maravai LifeSciences subsidiary — world-leading mRNA CDMO supplying CleanCap capping analogs and GMP-grade mRNA to Moderna, BioNTech, and 500+ biotech clients.
- Country
- United States
- Revenue
- ~$100M
- Employees
- ~500 emp
FDA GMP
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 1996 | trilinkbiotech.com |
| Production site | San Diego, California (multiple campus locations) and Jupiter, Florida | investors.maravai.com · sdbj.com · trilinkbiotech.com |
| Capacity | mRNA manufacturing capacity from 1g to >100g per batch; 118,000 sq ft manufacturing facility in San Diego; 5,000 sq ft GMP enzyme facility in Jupiter, Florida | investors.maravai.com · trilinkbiotech.com |
| Certification | ISO 9001:2015 and ICH Q7 compliant quality system | trilinkbiotech.com |
| Revenue | $119.8 million (for the year ended December 31, 2025) | investors.maravai.com · sec.gov |
Independent sources: investors.maravai.com · sdbj.com · sec.gov
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| mRNA platforms & LNP delivery | therapeutics-platforms | Medium | → |
| Prime editing | genome-engineering | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.